| Zugriffe | |
|---|---|
| Study protocol of the FIRE-8 (AIO-KRK/YMO-0519) trial: a prospective, randomized, open-label, multicenter phase II trial investigating the efficacy of trifluridine/tipiracil plus panitumumab versus trifluridine/tipiracil plus bevacizumab as first-line treatment in patients with metastatic colorectal cancer | 119 |
| November 2024 | Dezember 2024 | Januar 2025 | Februar 2025 | März 2025 | April 2025 | Mai 2025 | |
|---|---|---|---|---|---|---|---|
| Study protocol of the FIRE-8 (AIO-KRK/YMO-0519) trial: a prospective, randomized, open-label, multicenter phase II trial investigating the efficacy of trifluridine/tipiracil plus panitumumab versus trifluridine/tipiracil plus bevacizumab as first-line treatment in patients with metastatic colorectal cancer | 3 | 2 | 4 | 8 | 12 | 10 | 0 |
| Zugriffe | |
|---|---|
| 2022_Sommerhäuser_etal.pdf | 50 |
